Daniel Baty

6.2k total citations · 1 hit paper
120 papers, 5.0k citations indexed

About

Daniel Baty is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, Daniel Baty has authored 120 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Molecular Biology, 54 papers in Radiology, Nuclear Medicine and Imaging and 36 papers in Genetics. Recurrent topics in Daniel Baty's work include Monoclonal and Polyclonal Antibodies Research (53 papers), Bacterial Genetics and Biotechnology (33 papers) and RNA and protein synthesis mechanisms (24 papers). Daniel Baty is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (53 papers), Bacterial Genetics and Biotechnology (33 papers) and RNA and protein synthesis mechanisms (24 papers). Daniel Baty collaborates with scholars based in France, Russia and United States. Daniel Baty's co-authors include Patrick Chames, Étienne Weiss, Marc Van Regenmortel, Claude Lazdunski, F. Pattus, Pierre Chambon, Roger D. Everett, Vincent Géli, Denis Duché and Jeremy H. Lakey and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Daniel Baty

119 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapeutic antibodies: successes, limitations and hopes for the future

2009 1.1k citations Patrick Chames, Daniel Baty et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Baty France	37	3.2k	1.7k	1.1k	1.0k	829	120	5.0k
Per‐Åke Nygren Sweden	44	5.2k 1.6×	3.5k 2.1×	734 0.7×	736 0.7×	923 1.1×	141	7.0k
Hans Binz Switzerland	45	3.7k 1.2×	2.8k 1.7×	509 0.5×	2.2k 2.2×	715 0.9×	127	6.8k
Izumi Kumagai Japan	34	3.1k 1.0×	1.6k 1.0×	410 0.4×	1.2k 1.2×	549 0.7×	175	5.0k
Margreet A. Wolfert United States	41	4.8k 1.5×	1.2k 0.7×	846 0.8×	1.2k 1.2×	346 0.4×	76	6.7k
H. Mario Geysen Australia	41	3.6k 1.1×	2.5k 1.5×	346 0.3×	1.5k 1.5×	304 0.4×	87	7.1k
Andrew Bradbury United States	41	4.0k 1.2×	2.8k 1.7×	434 0.4×	1.0k 1.0×	396 0.5×	162	6.1k
Jens Schneider‐Mergener Germany	47	5.2k 1.6×	1.4k 0.8×	557 0.5×	1.7k 1.6×	1.1k 1.3×	124	7.5k
Rudolf Volkmer Germany	47	6.1k 1.9×	770 0.5×	471 0.4×	984 1.0×	753 0.9×	155	8.1k
Clifford P. Stanners Canada	42	3.5k 1.1×	1.7k 1.0×	801 0.8×	777 0.8×	1.6k 1.9×	99	5.9k
Peter J. Schatz United States	28	3.3k 1.0×	867 0.5×	748 0.7×	476 0.5×	286 0.3×	56	4.8k

Countries citing papers authored by Daniel Baty

Since Specialization

Citations

This map shows the geographic impact of Daniel Baty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Baty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Baty more than expected).

Fields of papers citing papers by Daniel Baty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Baty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Baty. The network helps show where Daniel Baty may publish in the future.

Co-authorship network of co-authors of Daniel Baty

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Baty. A scholar is included among the top collaborators of Daniel Baty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Baty. Daniel Baty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bode, Julia, Alyona Sukhanova, Svetlana Bozrova, et al.. (2018). Single- and two-photon imaging of human micrometastases and disseminated tumour cells with conjugates of nanobodies and quantum dots. Scientific Reports. 8(1). 4595–4595. 32 indexed citations

Scholler, Pauline, Damien Névoltris, Dimitri De Bundel, et al.. (2017). Allosteric nanobodies uncover a role of hippocampal mGlu2 receptor homodimers in contextual fear consolidation. Nature Communications. 8(1). 1967–1967. 61 indexed citations

Moreau, Alain, Laurence Meyer, Cécile Goujard, et al.. (2014). Adaptation of HIV-1 Envelope Glycoprotein gp120 to Humoral Immunity over the Course of the Epidemic. AIDS Research and Human Retroviruses. 30(S1). A224–A224.

Chames, Patrick, et al.. (2014). A FcγRIII-engaging bispecific antibody expands the range of HER2-expressing breast tumors eligible to antibody therapy. Oncotarget. 5(14). 5304–5319. 36 indexed citations

Rakovich, Tatsiana, Bashir M. Mohamed, Adriele Prina‐Mello, et al.. (2014). Highly Sensitive Single Domain Antibody–Quantum Dot Conjugates for Detection of HER2 Biomarker in Lung and Breast Cancer Cells. ACS Nano. 8(6). 5682–5695. 83 indexed citations

Cornillon, Amélie, Martine Chartier, Ghislaine Béhar, et al.. (2013). Single-Domain Antibody–Based and Linker-Free Bispecific Antibodies Targeting FcγRIII Induce Potent Antitumor Activity without Recruiting Regulatory T Cells. Molecular Cancer Therapeutics. 12(8). 1481–1491. 58 indexed citations

Even-Desrumeaux, Klervi, Patrick Fourquet, Véronique Secq, Daniel Baty, & Patrick Chames. (2012). Single-domain antibodies: a versatile and rich source of binders for breast cancer diagnostic approaches. Molecular BioSystems. 8(9). 2385–2394. 26 indexed citations

Kessler, Pascal, Jean-Louis Bouchet, Daniel Baty, et al.. (2012). Straightforward selection of broadly neutralizing single-domain antibodies targeting the conserved CD4 and co-receptor binding sites of HIV-1 gp120. Retrovirology. 9(S2). 1 indexed citations

Even-Desrumeaux, Klervi, Daniel Baty, & Patrick Chames. (2010). Strong and oriented immobilization of single domain antibodies from crude bacterial lysates for high-throughput compatible cost-effective antibody array generation. Molecular BioSystems. 6(11). 2241–2248. 29 indexed citations

10.

Alvarez-Rueda, Nidia, Maha Zohra Ladjemi, Ghislaine Béhar, et al.. (2009). A llama single domain anti-idiotypic antibody mimicking HER2 as a vaccine: Immunogenicity and efficacy. Vaccine. 27(35). 4826–4833. 32 indexed citations

11.

Chames, Patrick & Daniel Baty. (2009). Bispecific antibodies for cancer therapy. mAbs. 1(6). 539–547. 270 indexed citations

12.

Béhar, Ghislaine, Sophie Sibéril, Patrick Chames, et al.. (2007). Isolation and characterization of anti-Fc RIII (CD16) llama single-domain antibodies that activate natural killer cells. Protein Engineering Design and Selection. 21(1). 1–10. 72 indexed citations

13.

Baty, Daniel & Patrick Chames. (2006). Le point sur les anticorps autorisés en imagerie et en immunothérapie. Immuno-analyse & Biologie Spécialisée. 21(5). 255–263. 1 indexed citations

14.

Estienne, Valérie, Christine Duthoit, Roland Montserret, et al.. (2002). Analysis of a conformational B cell epitope of human thyroid peroxidase: identification of a tyrosine residue at a strategic location for immunodominance. International Immunology. 14(4). 359–366. 22 indexed citations

15.

Pèlegrin, André, Françoise Xavier, Jacques Barbet, et al.. (2000). Immunociblage des tumeurs : situation et perspectives en 2000. Bulletin du Cancer. 87(11). 1 indexed citations

16.

Nordén, Bengt, et al.. (1992). Structure of DNA-RecA complexes studied by residue differential linear dichroism and fluorescence spectroscopy for a genetically engineered RecA protein. Journal of Molecular Biology. 226(4). 1193–1205. 24 indexed citations

17.

Baty, Daniel, Jeremy H. Lakey, F. Pattus, & Claude Lazdunski. (1990). A 136‐amino‐acid‐residue COOH‐terminal fragment of colicin A is endowed with ionophoric activity. European Journal of Biochemistry. 189(2). 409–413. 26 indexed citations

18.

Géli, Vincent, Daniel Baty, Martine Knibiehler, et al.. (1989). Synthesis and sequence-specific proteolysis of a hybrid protein (colicin A :: growth hormone releasing factor) produced in Escherichia coli. Gene. 80(1). 129–136. 10 indexed citations

19.

Lloubès, Roland, Daniel Baty, & Claude Lazdunski. (1988). Transcriptional terminators in thecaa-caloperon andcaigene. Nucleic Acids Research. 16(9). 3739–3749. 11 indexed citations

20.

Baty, Daniel, Odile Mercereau‐Puijalon, David M. Perrin, Philippe Kourilsky, & Claude Lazdunski. (1981). Secretion into the bacterial periplasmic space of chicken ovalbumin synthesized in Escherichia coli. Gene. 16(1-3). 79–87. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact